Lung Cancer Therapeutics Market Trends, Size, Forecast - 2018-2023

Lung cancer therapeutics market is expected to grow at the CAGR of 13% during 2018-2023. The global lung cancer therapeutics market is growing at a modest rate due to rise in incidence prevalence rate of lung cancer across the globe. The adoption of lung cancer drugs and innovative lung surgeries are expected to boost the global lung cancer therapeutics market. In addition, huge demand is created by rising diagnostic centres across the globe. Investment and grants from government and private players are driving the market. Successful clinical trials and FDA approval are the key factors creating huge scope in global lung cancer therapeutics market. Number of prescriptions for lung cancer therapeutics market drugs such as Platinol, Taxol, Gemzar, Alimta, Iressa, Xalkori & Tarceva is increasing. Personalized medicines and drug discovery & development has significant contribution in the growth of lung cancer therapeutics market.

Request a free sample of our report on Lung Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/lung-cancer-therapeutics-market

In addition, there are several other factors that are driving the market to grow such as the initiative taken by the government, rising awareness within individuals related to carcinogenic effects of smoking. Different nations imply different fines on smoking in public places. New combine therapies are being utilized for the treatment of the lung cancer. The market is also driven by the increase in the number of smokers globally. As per the Tobacco Atlas organization, in the year 2014, 5.8 trillion cigarettes were smoked globally. There are several different factors that tends to drive the market such as rising pollution due to urbanization, changing lifestyle, increasing number of lung cancer patients, and technological developments such as utilization of biomarkers for recognition of lung cancer.

A full report of Lung Cancer Therapeutics Market Is available at https://www.omrglobal.com/industry-reports/lung-cancer-therapeutics-market

Lung Cancer Therapeutics Market segmentation

By drugs
• Platinol
• Taxol
• Gemzar
• Alimta
• Iressa
• Hycamtin
• Gilotrif
• Taxotere
• Xalkori
• Navelbine
• Avastin
• Tarceva
• Others

By therapy
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• Others

By end user
• Multispeciality hospitals
• Cancer research centers

Competitive landscape
• Market share analysis
• Key company analysis

Regional analysis
• North american
o United states
o Canada

• Europe
o U.k
o Germany
o Italy
o Spain
o France
o Roe

• Asia pacific
o India
o China
o Japan
o Roapac
• Rest of the world

Company profiles
• Abbvie
• Agennix
• Amgen
• Astrazeneca
• Boehringer ingelheim
• Celgene
• Celldex
• Eisai
• Eli lilly
• F. Hoffmann-la roche

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/lung-cancer-therapeutics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.